Physician profile
Yan Liu
NPI 1215036371
$930.37
in general payments reported to CMS, 2019-2025
13 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.37 · 2022: $11.71 · 2023: $111 · 2024: $592 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $268.74 | 2023-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $186.53 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $101.78 | 2022-2024 | Jardiance, Zepbound |
| Abbott Laboratories | $83.47 | 2024-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $63.29 | 2023-2024 | |
| Abbvie INC. | $50.22 | 2024-2025 | |
| Antares Pharma, INC. | $43.96 | 2024 | Xyosted |
| Amgen INC. | $30.92 | 2024 | Repatha |
| Amneal Pharmaceuticals LLC | $28.75 | 2025 | Unithroid |
| Dexcom, INC. | $20.15 | 2024 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $17.78 | 2024 | Licart, Tirosint, Flector |
| Phathom Pharmaceuticals, INC. | $17.41 | 2024 | Voquezna |
| Sanofi-Aventis U.S. LLC | $17.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.